Small molecule · Antagonist of orexin 1 receptor (HCRTR1) · developed by Indivior
Phase 2Most advanced trial (none active)
1Registered trials
What is INDV-2000?
INDV-2000 (also known as IDV-184001) is a highly potent and selective orexin 1 receptor (OX1R) antagonist. It is being studied for the treatment of opioid use disorder.
Summary written with AI from the sources listed at the end of this page.
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z
This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.